MSDS
Bayer Environmental Science
Material Safety Data Sheet
MSDS Number: 102000011911
BAYER ADVANCED COMPLETE BRAND INSECT KILLER
FOR SOIL & TURF READY-TO-SPREAD GRANULES
MSDS Version 1.0
Page 4 of 7
SECTION 11. TOXICOLOGICAL INFORMATION
Acute toxicity studies for this product have been bridged from another product containing a higher percentage
of the active ingredients Beta-cyfluthrin (1.35%), an enriched isomer mixture of Cyfluthrin and Imidacloprid
(10%). The non-acute information pertains to the active ingredients, Beta-cyrluthrin techinical, Cyfluthrin
technical, and Imidacloprid technical. Toxicology information on Cyfluthrin technical can be obtained by calling
the Product Use Information Number on page 1.
Acute Oral Toxicity
male/female rat: LD50: > 2,000 mg/kg
Acute Dermal Toxicity
male/female rat: LD50: > 4,000 mg/kg
Acute Inhalation Toxicity
male/female rat: LC50: > 1.2 mg/l
Exposure time: 4 h
Maximum attainable concentration.
Determined in the form of liquid aerosol.
(actual)
male/female rat: LC50: > 4.8 mg/l
Exposure time: 1 h
Determined in the form of liquid aerosol.
Extrapolated from the 4 hr LC50.
(actual)
Skin Irritation
rabbit: non-irritant
Eye Irritation
rabbit: non-irritant
Sensitization
guinea pig: Non-sensitizing
Subchronic Toxicity
BETA-CYFLUTHRIN TECHNICAL
In a subchronic dietary study, dogs treated with beta-cyfluthrin, exhibited
vomiting, diarrhea, decreased body weight gain and clinical neurological
symptoms at the highes dose level (360 ppm).
In a subchronic dietary study in rats treated with beta-cyfluthrin, effects included
reduced body weight gains and feed consumption, uncoordinated gait, and skin
injuries of the neck and head from excessive preening due to the local irritant
effect of the test material.
In a 4-week inhalation study in rats exposed to beta-cyfluthrin, effects observed
included ungroomed fur, piloerection, hyper- and hypoactivity, reduced body
weight gains, hematological changes and reduced organ weights (thymus,
spleen).
IMIDACLOPRID TECHNICAL
In a 3-week dermal toxicity study, rabbits treated with imidacloprid showed no







